Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

COLQ Antikörper (C-Term)

Dieses Anti-COLQ-Antikörper ist ein Kaninchen Polyklonal-Antikörper zur Detektion von COLQ in WB. Geeignet für Human und Maus. Dieses Primary Antibody wurde in 3+ Publikationen zitiert.
Produktnummer ABIN1881222

Kurzübersicht für COLQ Antikörper (C-Term) (ABIN1881222)

Target

Alle COLQ Antikörper anzeigen
COLQ (AChE Q Subunit (COLQ))

Reaktivität

  • 24
  • 17
  • 10
  • 2
  • 1
  • 1
  • 1
Human, Maus

Wirt

  • 23
  • 1
Kaninchen

Klonalität

  • 24
Polyklonal

Konjugat

  • 12
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser COLQ Antikörper ist unkonjugiert

Applikation

  • 17
  • 10
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB)

Klon

RB30589
  • Bindungsspezifität

    • 8
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 324-353, C-Term

    Homologie

    Rat

    Aufreinigung

    This antibody is purified through a protein A column, followed by peptide affinity purification.

    Immunogen

    This COLQ antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 324-353 amino acids from the C-terminal region of human COLQ.

    Isotyp

    Ig Fraction
  • Applikationshinweise

    WB: 1:1000

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Buffer

    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C,-20 °C

    Haltbarkeit

    6 months
  • Mihaylova, Müller, Vilchez, Salih, Kabiraj, DAmico, Bertini, Wölfle, Schreiner, Kurlemann, Rasic, Siskova, Colomer, Herczegfalvi, Fabriciova, Weschke, Scola, Hoellen, Schara, Abicht, Lochmüller: "Clinical and molecular genetic findings in COLQ-mutant congenital myasthenic syndromes." in: Brain : a journal of neurology, Vol. 131, Issue Pt 3, pp. 747-59, (2008) (PubMed).

    Schreiner, Hoppenz, Klaeren, Reimann, Woelfle: "Novel COLQ mutation 950delC in synaptic congenital myasthenic syndrome and symptomatic heterozygous relatives." in: Neuromuscular disorders : NMD, Vol. 17, Issue 3, pp. 262-5, (2007) (PubMed).

    Ishigaki, Nicolle, Krejci, Leroy, Koenig, Fardeau, Eymard, Hantaï: "Two novel mutations in the COLQ gene cause endplate acetylcholinesterase deficiency." in: Neuromuscular disorders : NMD, Vol. 13, Issue 3, pp. 236-44, (2003) (PubMed).

  • Target

    COLQ (AChE Q Subunit (COLQ))

    Andere Bezeichnung

    COLQ

    Hintergrund

    This gene encodes the subunit of a collagen-like molecule associated with acetylcholinesterase in skeletal muscle. Each molecule is composed of three identical subunits. Each subunit contains a proline-rich attachment domain (PRAD) that binds an acetylcholinesterase tetramer to anchor the catalytic subunit of the enzyme to the basal lamina. Mutations in this gene are associated with endplate acetylcholinesterase deficiency. Multiple transcript variants encoding different isoforms have been found for this gene.

    Molekulargewicht

    47766

    NCBI Accession

    NP_005668, NP_536799, NP_536800

    UniProt

    Q9Y215
Sie sind hier:
Chat with us!